跳至主要内容
临床试验/NL-OMON54012
NL-OMON54012已完成不适用

Benesco for reflux symptoms: efficacy and mechanism of action - Benesco for reflux symptoms

Academisch Medisch Centrum0 个研究点目标入组 108 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age above 18 years.
  • - Symptoms of heartburn and/or acid regurgitation at least 3 times a week
  • - A total reflux symptom score >=8 (measured through the GerdQ questionnaire

排除标准

  • - Use of any medication with an effect on gastrointestinal motility, secretion
  • or sensitivity that cannot be stopped for the duration of the study except
  • antacids (e.g. proton pump inhibitors, H2-blockers, antidepressants,
  • prokinetics). Medication must be stopped at least two weeks upon inclusion.
  • - Less than 50% response to PPI (if previously used)
  • - Known Barrett*s esophagus
  • - History of gastric or esophageal surgery
  • - Known allergy to one of the ingredients of Benesco
  • - Severe and clinically unstable concomitant disease (e.g. liver,
  • cardiovascular or lung disease, neurological or psychiatric disorders, cancer
  • or AIDS and other endocrine disorders)
  • - Pregnant, lactating or fertile women (without contraception)

研究者

相似试验